Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shanghai
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Guangxi Future Technology Co Ltd

+ Add to Watchlist

600556:CH

17.700 CNY 0.120 0.68%

As of 03:05:14 ET on 04/01/2015.

Snapshot for Guangxi Future Technology Co Ltd (600556)

Open: 17.500 Day's Range: 17.420 - 17.890 Volume: 8,533,978
Previous Close: 17.580 52wk Range: 4.770 - 18.220 1-Yr Rtn: +307.83%

Stock Chart for 600556

No chart data available.
  • 600556:CH 17.700
  • 1D
  • 1M
  • 1Y
17.580
Interactive 600556 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 600556

Current P/E Ratio (ttm) 204.1523
Estimated P/E(-) -
Relative P/E vs. SHASHR 10.9472
Earnings Per Share (ttm) 0.0867
Est. EPS -
Est. PEG Ratio -
Market Cap (M CNY) 6,987.85
Shares Outstanding (M) 394.79
30 Day Average Volume 13,328,220
Price/Book (mrq) 4,262.1429
Price/Sale (ttm) 154.3996
Dividend Indicated Gross Yield -%
Cash Dividend (CNY) -
Dividend Ex-Date 12/28/2009
5 Year Dividend Growth -
Next Earnings Announcement 04/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 600556

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 600556

Guangxi Future Technology Co., Ltd. researches, develops, and produces blood, biochemical, and dermatological pharmaceuticals. The Company's main products include blood albumin, interferon, and thymus peptides.

He JingyunChairman/Secretary
More Company Profile & Key Executives for 600556

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil